Gubra has actually not gotten any type of additional details regarding the choice.
发布者：BY MIKKEL AABENHUS HEMMINGSEN，转转请注明出处：https://robotalks.cn/boehringer-ingelheim-stops-development-of-gubra-obesity-drug/
Boehringer Ingelheim stops development of Gubra obesity drug
赞 (0)
关于作者
Spero Therapeutics fails midway – reduces workforce by 39%
上一篇
3 11 月, 2024 2:20 下午
Lundbeck closer to launching Vyepti in Asia after Phase 3 success
下一篇
3 11 月, 2024 2:20 下午
相关推荐
-
FREYR Battery Reports Third Quarter 2024 Results
NEW YORK CITY & OSLO, Norway & NEWNAN, Ga.–( SERVICE CABLE)– FREYR Battery, Inc. (NYSE: FREY) (” FREYR” or the “Firm”), a designer of …
-
Vilnius-based RedTrack raises €2.9 million to equip media buyers with AI-powered analytics and automation
RedTrack, an AI-driven analytics and automation system for media purchasers, has actually shut a EUR2.9 million Collection A financing round. The round was led by LeadVentures with…
-
‘Critically endangered’ African penguins just want peace and food
Mashudu Mashau claims it takes around 2 mins to capture a penguin, a job he does regular to explore discoveries of damaged or sickly seabirds.
-
GM Invests $625M in EV Battery Material Mining Operation
GM is intending to resource even more of its resources for electrical automobiles from the U.S, to handle battery cell prices and reduce its dependence on imported products.
